3-Bromo-6-chloroimidazo[1,2-b]pyridazine hydrobromide

Catalog No.: 
ACVJGZ318
CAS No.: 
80743-55-1
Molecular Formula: 
C6H4Br2ClN3
Molecular Weight: 
313.38
3-Bromo-6-chloroimidazo[1,2-b]pyridazine hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$65.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6-chloroimidazo[1,2-b]pyridazine hydrobromide
IUPAC Name3-bromo-6-chloroimidazo[1,2-b]pyridazine hydrobromide
MDL No.MFCD20527017
Molecular FormulaC6H4Br2ClN3
Molecular Weight313.38
SMILESClC1=NN2C(C=C1)=NC=C2Br.[H]Br
InChI KeyHIPUZDDUSBVRAD-UHFFFAOYSA-N
SynonymImidazo[1,2-b]pyridazine, 3-bromo-6-chloro-, hydrobromide (1:1);3-Bromo-6-chloroimidazo[1,2-b]pyridazine hydrobromide
CAS No.80743-55-1

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVJGZ318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTEVU478 route compound structure diagram
    ACTEVU4786775-78-6In Stock
  4. Then
  5. ACVJGZ318 route product structure diagram
    ACVJGZ31880743-55-1
Inquiry

2. ACVJGZ318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTEVU478 route compound structure diagram
    ACTEVU4786775-78-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVJGZ318 route product structure diagram
    ACVJGZ31880743-55-1
Inquiry

3. ACVJGZ318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTEVU478 route compound structure diagram
    ACTEVU4786775-78-6In Stock
  2. Then
  3. ACVJGZ318 route product structure diagram
    ACVJGZ31880743-55-1
Inquiry

Comments (0)